FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147071306> ?p ?o ?g. }

• W2147071306 endingPage "140" @default.
• W2147071306 startingPage "133" @default.
• W2147071306 abstract "The Absorb everolimus-eluting bioresorbable vascular scaffold (AbsorbBVS) is a completely resorbable device engineered to overcome the limitations of permanent metallic stents, providing temporary scaffolding and antiproliferative drug delivery for the treatment of obstructive coronary artery disease. The objective of the AIDA trial is to evaluate the efficacy and performance in an contemporary all-comer population of the AbsorbBVS strategy vs the XIENCE family everolimus-eluting metallic coronary stent system in the treatment of coronary lesions. The AIDA trial is a prospective, randomized (1:1), active-control, single-blinded, all-comer, noninferiority trial. A total of 2,690 subjects will be enrolled with broad inclusion and limited exclusion criteria according to the “Instructions for Use” of the AbsorbBVS strategy. The study population includes both simple and complex lesions, in patients with stable and acute coronary syndrome. The follow-up continues for 5 years. The primary end point of the trial is target vessel failure, defined as the composite of cardiac death, myocardial infarction, and target vessel revascularization, at 2 years. This study is registered on ClinicalTrials.gov with number NCT01858077. The AIDA trial will provide the first randomized direct comparison between the everolimus-eluting bioresorbable vascular scaffold and the everolimus-eluting metallic stent in contemporary percutaneous coronary intervention practice." @default.
• W2147071306 created "2016-06-24" @default.
• W2147071306 creator A5003578699 @default.
• W2147071306 creator A5006701743 @default.
• W2147071306 creator A5010426969 @default.
• W2147071306 creator A5012791093 @default.
• W2147071306 creator A5023923650 @default.
• W2147071306 creator A5026989499 @default.
• W2147071306 creator A5034234308 @default.
• W2147071306 creator A5039055954 @default.
• W2147071306 creator A5052265401 @default.
• W2147071306 creator A5054452062 @default.
• W2147071306 creator A5077532206 @default.
• W2147071306 creator A5086208942 @default.
• W2147071306 creator A5091465562 @default.
• W2147071306 date "2014-02-01" @default.
• W2147071306 modified "2023-10-14" @default.
• W2147071306 title "Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design" @default.
• W2147071306 cites W1495832539 @default.
• W2147071306 cites W163964307 @default.
• W2147071306 cites W2009589924 @default.
• W2147071306 cites W2040715270 @default.
• W2147071306 cites W2044598564 @default.
• W2147071306 cites W2054094388 @default.
• W2147071306 cites W2087150869 @default.
• W2147071306 cites W2109100788 @default.
• W2147071306 cites W2117341445 @default.
• W2147071306 cites W2125716797 @default.
• W2147071306 cites W2137841492 @default.
• W2147071306 cites W2149148362 @default.
• W2147071306 cites W2150086052 @default.
• W2147071306 cites W2157573306 @default.
• W2147071306 cites W2160631086 @default.
• W2147071306 cites W2166950143 @default.
• W2147071306 cites W2548646455 @default.
• W2147071306 cites W2615022822 @default.
• W2147071306 cites W2762639187 @default.
• W2147071306 cites W3030817736 @default.
• W2147071306 cites W4293577771 @default.
• W2147071306 cites W56280568 @default.
• W2147071306 doi "https://doi.org/10.1016/j.ahj.2013.09.017" @default.
• W2147071306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24439973" @default.
• W2147071306 hasPublicationYear "2014" @default.
• W2147071306 type Work @default.
• W2147071306 sameAs 2147071306 @default.
• W2147071306 citedByCount "40" @default.
• W2147071306 countsByYear W21470713062014 @default.
• W2147071306 countsByYear W21470713062015 @default.
• W2147071306 countsByYear W21470713062016 @default.
• W2147071306 countsByYear W21470713062017 @default.
• W2147071306 countsByYear W21470713062018 @default.
• W2147071306 countsByYear W21470713062019 @default.
• W2147071306 countsByYear W21470713062020 @default.
• W2147071306 countsByYear W21470713062022 @default.
• W2147071306 crossrefType "journal-article" @default.
• W2147071306 hasAuthorship W2147071306A5003578699 @default.
• W2147071306 hasAuthorship W2147071306A5006701743 @default.
• W2147071306 hasAuthorship W2147071306A5010426969 @default.
• W2147071306 hasAuthorship W2147071306A5012791093 @default.
• W2147071306 hasAuthorship W2147071306A5023923650 @default.
• W2147071306 hasAuthorship W2147071306A5026989499 @default.
• W2147071306 hasAuthorship W2147071306A5034234308 @default.
• W2147071306 hasAuthorship W2147071306A5039055954 @default.
• W2147071306 hasAuthorship W2147071306A5052265401 @default.
• W2147071306 hasAuthorship W2147071306A5054452062 @default.
• W2147071306 hasAuthorship W2147071306A5077532206 @default.
• W2147071306 hasAuthorship W2147071306A5086208942 @default.
• W2147071306 hasAuthorship W2147071306A5091465562 @default.
• W2147071306 hasBestOaLocation W21470713061 @default.
• W2147071306 hasConcept C126322002 @default.
• W2147071306 hasConcept C141071460 @default.
• W2147071306 hasConcept C168563851 @default.
• W2147071306 hasConcept C2777698277 @default.
• W2147071306 hasConcept C2778213512 @default.
• W2147071306 hasConcept C2778583881 @default.
• W2147071306 hasConcept C2779464278 @default.
• W2147071306 hasConcept C2779699572 @default.
• W2147071306 hasConcept C2780400711 @default.
• W2147071306 hasConcept C2908647359 @default.
• W2147071306 hasConcept C500558357 @default.
• W2147071306 hasConcept C535046627 @default.
• W2147071306 hasConcept C71924100 @default.
• W2147071306 hasConcept C99454951 @default.
• W2147071306 hasConceptScore W2147071306C126322002 @default.
• W2147071306 hasConceptScore W2147071306C141071460 @default.
• W2147071306 hasConceptScore W2147071306C168563851 @default.
• W2147071306 hasConceptScore W2147071306C2777698277 @default.
• W2147071306 hasConceptScore W2147071306C2778213512 @default.
• W2147071306 hasConceptScore W2147071306C2778583881 @default.
• W2147071306 hasConceptScore W2147071306C2779464278 @default.
• W2147071306 hasConceptScore W2147071306C2779699572 @default.
• W2147071306 hasConceptScore W2147071306C2780400711 @default.
• W2147071306 hasConceptScore W2147071306C2908647359 @default.
• W2147071306 hasConceptScore W2147071306C500558357 @default.
• W2147071306 hasConceptScore W2147071306C535046627 @default.
• W2147071306 hasConceptScore W2147071306C71924100 @default.
• W2147071306 hasConceptScore W2147071306C99454951 @default.
• W2147071306 hasIssue "2" @default.

• next